Neuroblastoma (NB)
Clinical trials for Neuroblastoma (NB) explained in plain language.
Never miss a new study
Get alerted when new Neuroblastoma (NB) trials appear
Sign up with your email to follow new studies for Neuroblastoma (NB), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a radioactive compound outsmart resistant neuroblastoma?
Disease control Recruiting nowThis early-phase trial is exploring whether a radioactive drug called [211At]MABG, given in several smaller doses, is safe and tolerable for children with neuroblastoma that has relapsed or not responded to treatment. The study will include about 10 participants aged 1 year and o…
Matched conditions: NEUROBLASTOMA (NB)
Early phase 1 • Sponsor: Sichuan University • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
New drug cocktail aims to fight tough childhood cancer
Disease control Recruiting nowThis phase II trial tests a combination of four drugs—chidamide, dinutuximab beta, irinotecan, and temozolomide—in 27 children whose neuroblastoma has returned or not responded to standard treatment. The goal is to see how well the regimen controls the cancer and to monitor side …
Matched conditions: NEUROBLASTOMA (NB)
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New hope for kids with aggressive nerve cancer: immune-boosting combo trial opens
Disease control Recruiting nowThis phase 3 trial tests a powerful mix of chemotherapy, immunotherapy, and the child's own natural killer (NK) cells for children aged 1.5 to 18 with high-risk neuroblastoma that didn't respond or came back. The goal is to shrink tumors and improve survival by helping the immune…
Matched conditions: NEUROBLASTOMA (NB)
Phase 3 • Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC